Fumarylacetoacetate
Fumarylacetoacetate | |
---|---|
Synonyms | N/A |
Pronounce | N/A |
Specialty | N/A |
Symptoms | N/A |
Complications | N/A |
Onset | N/A |
Duration | N/A |
Types | N/A |
Causes | N/A |
Risks | N/A |
Diagnosis | N/A |
Differential diagnosis | N/A |
Prevention | N/A |
Treatment | N/A |
Medication | N/A |
Prognosis | N/A |
Frequency | N/A |
Deaths | N/A |
Fumarylacetoacetate is an important intermediate in the metabolic pathway known as the tyrosine catabolism pathway. It is a compound that plays a crucial role in the breakdown of the amino acid tyrosine.
Biochemical Role[edit | edit source]
Fumarylacetoacetate is formed during the catabolism of tyrosine, which is an essential process for the production of energy and the synthesis of important biomolecules. The breakdown of tyrosine involves several steps, and fumarylacetoacetate is one of the key intermediates in this pathway.
Enzymatic Conversion[edit | edit source]
The enzyme fumarylacetoacetate hydrolase catalyzes the conversion of fumarylacetoacetate into fumarate and acetoacetate. This reaction is the final step in the tyrosine degradation pathway. Fumarate enters the citric acid cycle, while acetoacetate can be used as a source of energy.
Clinical Significance[edit | edit source]
Deficiency in fumarylacetoacetate hydrolase leads to a rare genetic disorder known as tyrosinemia type I. This condition results in the accumulation of fumarylacetoacetate and its derivatives, which are toxic to the liver and kidneys. Symptoms of tyrosinemia type I include liver failure, renal dysfunction, and neurological complications.
Diagnosis and Treatment[edit | edit source]
Diagnosis of tyrosinemia type I is typically confirmed through genetic testing and measurement of succinylacetone in the urine, a byproduct of fumarylacetoacetate accumulation. Treatment often involves dietary management to restrict tyrosine and phenylalanine intake, and the use of nitisinone, a drug that inhibits an upstream enzyme in the tyrosine degradation pathway, thereby reducing the formation of fumarylacetoacetate.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD